CareLit Fachartikel

First-Line Therapy Using Brigatinib vs. Crizotinib in Patients With Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Results From a Phase 3 Trial

MJ Hochmair, DR Camidge, HR Kim, MJ Ahn, JCH Yang, J Youn Han, KH Lee, A Delmonte, MR Garcia Campelo, DW Kim, F Griesinger, E Felip, R Califano, A Spira, S Gettinger, M Tiseo, Q Ni, P Zhang, S Popat · Pneumologie · 2020 · Heft S 01 S 01

Dokument
1214627
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
MJ Hochmair, DR Camidge, HR Kim, MJ Ahn, JCH Yang, J Youn Han, KH Lee, A Delmonte, MR Garcia Campelo, DW Kim, F Griesinger, E Felip, R Califano, A Spira, S Gettinger, M Tiseo, Q Ni, P Zhang, S Popat
Ausgabe
Heft S 01 S 01 / 2020
Jahrgang 74
Seiten
–
Erschienen: 2020-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-3403360

Zusammenfassung

First-Line Therapy Using Brigatinib vs. Crizotinib in Patients With Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Results From a Phase 3 Trial

Schlagworte

Anaplastic Lymphoma Kinase Crizotinib Pneumologie